Kruger, Terra M. https://orcid.org/0000-0002-4977-2875
Valenzuela, Belén https://orcid.org/0000-0002-2317-5028
Thompson, Charles D. https://orcid.org/0000-0002-6206-7345
Ouwerkerk-Mahadevan, Sivi https://orcid.org/0000-0001-9150-923X
Ruixo, Juan Jose Perez https://orcid.org/0000-0001-9890-745X
Funding for this research was provided by:
Janssen Research and Development
Article History
Accepted: 4 September 2023
First Online: 30 September 2023
Declarations
:
: All authors hold stock in Johnson & Johnson.
: This study is supported by Actelion Pharmaceuticals, Part of Janssen Pharmaceutical Companies, Allschwil, Switzerland.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Protocols were reviewed and approved by an institutional review board.
: Freely given, informed consent to participate was obtained for all human participants in this study.
: Not applicable.
: Data sharing/availability is not applicable to this manuscript as no new data were created or analyzed for this review article.
: Not applicable.
: All authors participated in the original design of the manuscript, monitored literature data and contributed to the data interpretation, development and review of this manuscript and confirm that they have read the journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. All authors meet ICMJE criteria and all those who fulfilled those criteria are listed as authors. All authors had access to the literature data, provided direction and comments on the manuscript, made the final decision about where to publish these data and approved submission to this journal.